Clinical trials in Uppsala – page 21

334 clinical trials in Uppsala, Sweden across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SwedenKliniska-Provningar.se

Uppsala at a glance

334

clinical trials

Research sites5

Quick filters

334 trials in Uppsala

Open in trial search

Graft versus host disease

Not recruiting

InvestigationalNo placebo

Study on the Safety of Decidua Stromal Cells for Patients with Steroid-Resistant Severe Acute Graft vs Host Disease

InvestigationalNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Allogeneic Placenta-Derived Decidual Stromal Cells, Ex-Vivo Expanded
Sponsor:Oslo University Hospital HF

Contact Research Centre

Bladder cancer

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab and Enfortumab Vedotin with Surgery vs. Surgery Alone for Patients with Muscle-Invasive Bladder Cancer Who Cannot or Choose Not to Use Cisplatin

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Pembrolizumab
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Hypertriglyceridaemia

Not recruiting

Registered drug

Study on the Safety of A24110He for Patients with Type 2 Diabetes and High Triglycerides

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:A24110He
Sponsor:Lipigon Pharmaceuticals AB

Contact Research Centre

B-cell lymphoma refractory

Not recruiting

Registered drugNo placebo

Study of Epcoritamab for Patients with Relapsed, Progressive, or Refractory B-Cell Lymphoma

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Anakinra
Sponsor:Genmab A/S

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Amivantamab, Lazertinib, and Drug Combination for Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer After Osimertinib Failure

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Amivantamab
Sponsor:Janssen Cilag International

Contact Research Centre

Non-small cell lung cancer+2

Not recruiting

Registered drug

Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Pembrolizumab
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on Durvalumab and Platinum-Based Drug Combination for Patients with Stage IIB-IIIB Non-Small Cell Lung Cancer

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Anhydrous Docetaxel
Sponsor:AstraZeneca AB

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Talquetamab, Pomalidomide, and Teclistamab for Patients with Relapsed or Refractory Myeloma After 1 to 4 Prior Treatments

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Bortezomib
Sponsor:Janssen Cilag International

Contact Research Centre

Hypertension

Not recruiting

Investigational

Study on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:Baxdrostat
Sponsor:AstraZeneca AB

Contact Research Centre

Sjogren's syndrome

Not recruiting

Registered drug

Study on Hydroxychloroquine, Leflunomide, and Mycophenolate Mofetil for Patients with Primary Sjogren's Syndrome

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Leflunomide
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Cholangitis sclerosing

Not recruiting

Registered drug

Study on Simvastatin for Treating Primary Sclerosing Cholangitis in Patients

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Simvastatin
Sponsor:Karolinska University Hospital

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study on Atezolizumab with Platinum-Based Chemotherapy for Patients with Early-Stage Resectable Non-Small Cell Lung Cancer

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Atezolizumab
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Other cities in Sweden

The busiest research cities in the country

All 65 cities in Sweden

Clinical research in Uppsala

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on metastatic breast cancer and prostate cancer treatments, including targeted therapies and novel drug combinations.

Advanced breast cancer treatments
Prostate cancer therapies
Colorectal cancer studies

Particular emphasis on HER2-positive breast cancer imaging and treatment optimization.

02 Metabolic Disorders

Research initiatives targeting obesity management and metabolic health, with studies evaluating new therapeutic approaches for weight management in both adults and adolescents.

Weight management treatments
Adolescent obesity studies
Metabolic health interventions

Focus on innovative drug combinations and long-term effectiveness studies.

03 Cardiovascular and Renal Studies

Comprehensive research on heart failure prevention and chronic kidney disease management, investigating new therapeutic combinations.

Heart failure prevention
Kidney disease treatments
Hypertension management

Emphasis on combination therapies and preventive approaches.

Back to Sweden All countries

Clinical trials in Uppsala – page 21

334 trials in Uppsala

Graft versus host disease

Study on the Safety of Decidua Stromal Cells for Patients with Steroid-Resistant Severe Acute Graft vs Host Disease

Bladder cancer

Study of Pembrolizumab and Enfortumab Vedotin with Surgery vs. Surgery Alone for Patients with Muscle-Invasive Bladder Cancer Who Cannot or Choose Not to Use Cisplatin

Hypertriglyceridaemia

Study on the Safety of A24110He for Patients with Type 2 Diabetes and High Triglycerides

B-cell lymphoma refractory

Study of Epcoritamab for Patients with Relapsed, Progressive, or Refractory B-Cell Lymphoma

Non-small cell lung cancer

Study of Amivantamab, Lazertinib, and Drug Combination for Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer After Osimertinib Failure

Non-small cell lung cancer+2

Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Non-small cell lung cancer

Study on Durvalumab and Platinum-Based Drug Combination for Patients with Stage IIB-IIIB Non-Small Cell Lung Cancer

Plasma cell myeloma

Study Comparing Talquetamab, Pomalidomide, and Teclistamab for Patients with Relapsed or Refractory Myeloma After 1 to 4 Prior Treatments

Hypertension

Study on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension

Sjogren's syndrome

Study on Hydroxychloroquine, Leflunomide, and Mycophenolate Mofetil for Patients with Primary Sjogren's Syndrome

Cholangitis sclerosing

Study on Simvastatin for Treating Primary Sclerosing Cholangitis in Patients

Non-small cell lung cancer

Study on Atezolizumab with Platinum-Based Chemotherapy for Patients with Early-Stage Resectable Non-Small Cell Lung Cancer

Filter the trials

Other cities in Sweden

Clinical research in Uppsala

Prefer not to search? Our Concierge searches the trials for you.

Clinical trials in Uppsala – page 21

334 trials in Uppsala

Non-small cell lung cancer+2

Other cities in Sweden

Related

Clinical research in Uppsala

Prefer not to search? Our Concierge searches the trials for you.